Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03147976 | QUILT-3.036: AMG 337 in Subjects With Advanced or Metastatic Solid Tumors | withdrawn | Phase 2 | 0 | NantPharma, LLCINDUSTRY | 1 | Aug 28, 2019 | clinicaltrials |
| NCT03166176 | Phase II Trial of Vistusertib（AZD2014） Single Agent in TSC1or 2 Null or TSC 1/2 Mutation Solid Cancer Patients Refractory to Standard Chemotherapy(TSC1/2_SC) | withdrawn | Phase 2 | 0 | Samsung Medical CenterOTHER | 1 | May 20, 2019 |
| NCT03166904 | Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy(RICTOR_SC) | withdrawn | Phase 2 | 0 | Samsung Medical CenterOTHER | 1 | May 20, 2019 | clinicaltrials |
| NCT00052221 | Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Nov 8, 2018 | clinicaltrials |
| NCT03496519 | Assessing the Combination of Durvalumab (MEDI4736) and Trabectedin in Solid Tumors | withdrawn | Phase 1 | 0 | University of Colorado, DenverOTHER | 0 | Oct 9, 2018 | clinicaltrials |
| NCT02845414 | Study of CD133KDEL Toxin in the Treatment for Solid Tumors | withdrawn | Phase 1 | 0 | Masonic Cancer Center, University of MinnesotaOTHER | 1 | Oct 3, 2018 | clinicaltrials |
| NCT00997360 | Study of PKI-179 Administered Orally to Subjects With Solid Tumors | withdrawn | Phase 1 | 0 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 0 | Sep 27, 2018 | clinicaltrials |
| NCT00296049 | Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT03326258 | Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 18, 2018 | clinicaltrials |
| NCT00820768 | A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies | withdrawn | Phase 1 | 0 | CelgeneINDUSTRY | 1 | Apr 11, 2018 | clinicaltrials |
| NCT03448211 | A Study of PTS for Patients With Solid Tumors | withdrawn | Phase 1 | 0 | PTS International Inc.INDUSTRY | 1 | Apr 5, 2018 | clinicaltrials |
| NCT01275612 | Mesenchymal Stem Cells In Cisplatin-Induced Acute Renal Failure In Patients With Solid Organ Cancers(CIS/MSC08) | withdrawn | Phase 1 | 0 | Mario Negri Institute for Pharmacological ResearchOTHER | 1 | Mar 21, 2018 | clinicaltrials |
| NCT03266159 | A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors | withdrawn | Phase 2 | 0 | GlaxoSmithKlineINDUSTRY | 0 | Dec 8, 2017 | clinicaltrials |
| NCT02674555 | A Study to Investigate the Absorption, Metabolism and Excretion of [14C]ASP8273 in Subjects With Solid Tumors | withdrawn | Phase 1 | 0 | Astellas Pharma Global Development, Inc.INDUSTRY | 0 | Jul 28, 2017 | clinicaltrials |
| NCT02766842 | Evaluation of a New EUS Guided Biopsy Needle (SharkCore) Comparing to Standard EUS Needle (ProCore) | withdrawn | Phase 2 | 0 | Johns Hopkins UniversityOTHER | 1 | May 15, 2017 | clinicaltrials |
| NCT02735798 | 64-Cu Labeled Brain PET/MRI for MM-302 in Advanced HER2+ Cancers With Brain Mets | withdrawn | Early Phase 1 | 0 | Pamela MunsterOTHER | 0 | May 4, 2017 | clinicaltrials |
| NCT00937417 | S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Apr 24, 2017 | clinicaltrials |
| NCT02567396 | Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Apr 24, 2017 | clinicaltrials |
| NCT02216669 | Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer | withdrawn | Phase 1 | 0 | Maastricht Radiation OncologyOTHER | 1 | Mar 3, 2017 | clinicaltrials |
| NCT00607802 | Donor White Blood Cell Infusion in Treating Patients With Metastatic or Unresectable Cancer | withdrawn | N/A | 0 | Wake Forest University Health SciencesOTHER | 0 | Jan 19, 2017 | clinicaltrials |
| NCT02126527 | Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer | withdrawn | Phase 1 | 0 | Mayo ClinicOTHER | 1 | Aug 26, 2016 | clinicaltrials |
| NCT02627430 | Talazoparib and HSP90 Inhibitor AT13387 in Treating Patients With Metastatic Advanced Solid Tumor or Recurrent Ovarian, Fallopian Tube, Primary Peritoneal, or Triple Negative Breast Cancer | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Jul 26, 2016 | clinicaltrials |
| NCT00041171 | Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT01473290 | Probiotic Therapy in Preventing Gastrointestinal Complications in Patients Undergoing Chemotherapy and Pelvic Radiation Therapy | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 6, 2016 | clinicaltrials |
| NCT02656849 | BAY 1000394 for MCL-1-, MYC-, and CCNE1-Amplified Tumors | withdrawn | Phase 2 | 0 | Dana-Farber Cancer InstituteOTHER | 1 | Jul 1, 2016 | clinicaltrials |
| NCT02537561 | Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Feb 11, 2016 | clinicaltrials |
| NCT00425906 | Nicotine in Treating "Hunger Pain" in Patients With Malignant Bowel Obstruction Caused By Cancer | withdrawn | N/A | 0 | Mayo ClinicOTHER | 0 | Jan 12, 2016 | clinicaltrials |
| NCT01245543 | Safety Study for Intravenous (IV) AC480 (AC480IV) to Treat Advanced Solid Tumors | withdrawn | Phase 1 | 0 | Daiichi SankyoINDUSTRY | 1 | Nov 2, 2015 | clinicaltrials |
| NCT00093678 | Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer | withdrawn | N/A | 0 | Eastern Cooperative Oncology GroupNETWORK | 0 | Oct 8, 2015 | clinicaltrials |
| NCT02462707 | A Study Of PF-03084014 In Japanese Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Oct 7, 2015 | clinicaltrials |
| NCT01501604 | BKM120 in Cancers With PIK3CA Activating Mutations | withdrawn | Phase 2 | 0 | Massachusetts General HospitalOTHER | 0 | Sep 17, 2015 | clinicaltrials |
| NCT00792558 | Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 2 | Sep 1, 2015 | clinicaltrials |
| NCT01490047 | Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas | withdrawn | Phase 1 | 0 | Ludwig Institute for Cancer ResearchOTHER | 1 | Jun 16, 2015 | clinicaltrials |
| NCT02120118 | Combination of Hyperthermia and Concurrent Chemoradiotherapy (CCRT) in Treatment Failure Solid Tumors | withdrawn | Phase 2 | 0 | Shin Kong Wu Ho-Su Memorial HospitalOTHER | 1 | Jun 9, 2015 | clinicaltrials |
| NCT00770419 | Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers | withdrawn | — | 0 | Rutgers, The State University of New JerseyOTHER | 0 | May 29, 2015 | clinicaltrials |
| NCT00899808 | Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer | withdrawn | — | 0 | Rutgers, The State University of New JerseyOTHER | 1 | May 29, 2015 | clinicaltrials |
| NCT00682279 | A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | GlaxoSmithKlineINDUSTRY | 1 | Apr 17, 2015 | clinicaltrials |
| NCT00769249 | Positive Changes in Quality of Life of Older Cancer Patients and Their Caregivers | withdrawn | — | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Mar 19, 2015 | clinicaltrials |
| NCT00788580 | S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Mar 6, 2015 | clinicaltrials |
| NCT02101164 | Evaluate Time Associated With the Preparation & Administration of Denosumab/Pamidronate in Patients With Solid Tumors and Metastatic Bone Disease | withdrawn | Phase 4 | 0 | AmgenINDUSTRY | 0 | Feb 18, 2015 | clinicaltrials |
| NCT01940601 | Pharmacodynamics, Pharmacokinetics, Efficacy and Safety of Balugrastim in Pediatric Patients With Solid Tumors | withdrawn | Phase 2 | 0 | Teva Branded Pharmaceutical Products R&D, Inc.INDUSTRY | 0 | Jan 14, 2015 | clinicaltrials |
| NCT02048943 | Dovitinib Lactate, Gemcitabine Hydrochloride, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Solid Tumors or Pancreatic Cancer | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 1 | Jan 9, 2015 | clinicaltrials |
| NCT00624962 | Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors | withdrawn | N/A | 0 | Vanderbilt UniversityOTHER | 0 | Dec 11, 2014 | clinicaltrials |
| NCT02033148 | Icotinib Hydrochloride in Treating Patients With Advanced Cancers | withdrawn | Phase 1 | 0 | Roswell Park Cancer InstituteOTHER | 0 | Nov 5, 2014 | clinicaltrials |
| NCT00458744 | Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to Treatment | withdrawn | Phase 1 | 0 | Children's Oncology GroupNETWORK | 0 | Aug 8, 2014 | clinicaltrials |
| NCT01170871 | Ixabepilone and Pemetrexed/Solid Tumors | withdrawn | Phase 1 | 0 | University of Southern CaliforniaOTHER | 1 | May 21, 2014 | clinicaltrials |
| NCT00601614 | Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery | withdrawn | Phase 1 | 0 | Mayo ClinicOTHER | 0 | Mar 10, 2014 | clinicaltrials |
| NCT01644097 | Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy | withdrawn | Phase 2 | 0 | Stanford UniversityOTHER | 1 | Feb 14, 2014 | clinicaltrials |
| NCT00052403 | Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors | withdrawn | Phase 1 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Jan 16, 2014 | clinicaltrials |
| NCT00923728 | A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors | withdrawn | N/A | 0 | Vertex Pharmaceuticals IncorporatedINDUSTRY | 1 | Jan 10, 2014 | clinicaltrials |
Data updated 22 days agoSource updated Aug 28, 2019source: clinicaltrials